Global Blood Therapeutics Probability of Future Stock Price Finishing Over 0.0
Global Blood's future price is the expected price of Global Blood instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Global Blood Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Please specify Global Blood's target price for which you would like Global Blood odds to be computed.
Global |
Global Blood Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Global Blood for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Global Blood Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Global Blood is not yet fully synchronised with the market data | |
| Global Blood has some characteristics of a very speculative penny stock | |
| Global Blood has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 210.87 M. Reported Net Loss for the year was (309.58 M) with profit before taxes, overhead, and interest of 191.43 M. | |
| Global Blood Therapeutics has about 553.42 M in cash with (249.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5. | |
| Over 97.0% of the company shares are owned by institutional investors |
Global Blood Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Global Stock often depends not only on the future outlook of the current and potential Global Blood's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Global Blood's indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 14.18% | |
| Short Percent Of Float | 14.58% | |
| Float Shares | 52.61M | |
| Shares Short Prior Month | 10.65M | |
| Average Daily Volume Last 10 Day | 2.06M | |
| Average Daily Volume In Three Month | 3.85M | |
| Date Short Interest | 15th of July 2022 |
Global Blood Technical Analysis
Global Blood's future price can be derived by breaking down and analyzing its technical indicators over time. Global Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Global Blood Therapeutics. In general, you should focus on analyzing Global Stock price patterns and their correlations with different microeconomic environments and drivers.
Global Blood Predictive Forecast Models
Global Blood's time-series forecasting models is one of many Global Blood's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Global Blood's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Global Blood Therapeutics
Checking the ongoing alerts about Global Blood for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Global Blood Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Global Blood is not yet fully synchronised with the market data | |
| Global Blood has some characteristics of a very speculative penny stock | |
| Global Blood has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 210.87 M. Reported Net Loss for the year was (309.58 M) with profit before taxes, overhead, and interest of 191.43 M. | |
| Global Blood Therapeutics has about 553.42 M in cash with (249.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5. | |
| Over 97.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Global Stock
If you are still planning to invest in Global Blood Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Global Blood's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |